COVID-19 information 2. Cardiovascular System Guidelines
Anticoagulation Guidance
DOAC Decision Aid Tool (July 2022)
Summary of considerations when prescribing a DOAC
BNSSG Guidance on switching between oral anticoagulants (July 2022)
BNSSG ICS Warfarin Counselling checklist
BNSSG ICS DOACs Counselling checklist
Management of Subtherapeutic INR in the community
Management of High INR in the community.
Anticoagulation Patient Information
Apixaban
-
Apixaban - A guide for patients with Atrial Fibrillation (available in 12 non-English languages)
Dabigatran
Edoxaban
-
Patient booklet for patients with NVAF prescribed Edoxaban (available in 9 non-English languages)
Rivaroxaban
-
Support for Patients with Atrial Fibrillation (available in 10 non-English languages)
-
Step 1 – Go to the following web address https://www.xarelto.co.uk/patients-atrial-fibrillation
-
Step 3 – Pick the required language
-
Antiplatelet Guidance
Antiplatelet Guidelines March 2021 BNSSG
Heart Failure Guidance
Primary Care Heart Failure Treatment Guideline
Practical Guidance on how to use Heart Failure Medications
Traffic light: How to monitor renal function and potassium rises in stable Heart Failure
See 'Endocrine System Guidelines' page for the 'Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease'
Lipid Guidance
BNSSG Management of Blood Lipid Levels
Inclisiran Clinical Guidelines
Inclisiran Information for Primary Care
AAC/NHSE Statin Intolerance Pathway
Management of Hypertriglyceridaemia in Primary Care